Tower Research Capital LLC (TRC) - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 156 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,902
-33.7%
945
-18.3%
0.00%
-100.0%
Q2 2023$22,492
+224820.0%
1,157
+217.0%
0.00%
Q1 2023$100.0%365
+2.2%
0.00%
Q4 2022$10
-100.0%
357
-95.5%
0.00%
-100.0%
Q3 2022$211,000
+305.8%
7,957
+578.3%
0.00%
+200.0%
Q2 2022$52,000
-59.7%
1,173
-55.2%
0.00%0.0%
Q1 2022$129,000
-33.5%
2,617
-31.2%
0.00%
-66.7%
Q4 2021$194,000
+203.1%
3,805
+230.6%
0.00%
+50.0%
Q3 2021$64,000
+93.9%
1,151
+50.3%
0.00%
+100.0%
Q2 2021$33,000
-21.4%
766
-24.7%
0.00%0.0%
Q1 2021$42,000
+366.7%
1,017
+441.0%
0.00%
Q4 2020$9,000
-71.9%
188
-75.4%
0.00%
Q3 2020$32,000
-67.7%
765
-63.0%
0.00%
-100.0%
Q2 2020$99,000
+2375.0%
2,066
+1886.5%
0.00%
Q4 2018$4,000
-85.2%
104
-71.3%
0.00%
-100.0%
Q2 2018$27,000
-73.8%
362
-81.5%
0.00%
-77.8%
Q1 2018$103,000
+692.3%
1,958
+695.9%
0.01%
+350.0%
Q4 2017$13,000
-59.4%
246
-37.1%
0.00%
-33.3%
Q1 2017$32,000
-68.9%
391
-69.9%
0.00%
-72.7%
Q4 2016$103,000
+10200.0%
1,300
+4233.3%
0.01%
Q1 2016$1,000
-88.9%
30
-70.0%
0.00%
-100.0%
Q4 2015$9,000
-87.3%
100
-89.5%
0.00%
-85.7%
Q3 2015$71,000
+1320.0%
954
+657.1%
0.01%
+600.0%
Q1 2015$5,000
+25.0%
126
-52.8%
0.00%
Q4 2014$4,000
-84.0%
267
-86.4%
0.00%
-100.0%
Q3 2014$25,000
+212.5%
1,966
+222.3%
0.00%
+200.0%
Q1 2014$8,0006100.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Tri Locum Partners LP 94,922$4,063,0001.33%
Smith, Graham & Co., Investment Advisors, LP 277,572$11,880,0001.05%
Krensavage Asset Management, LLC 70,804$3,030,0001.03%
BRANDES INVESTMENT PARTNERS, LP 716,873$30,682,0000.68%
GLOBEFLEX CAPITAL L P 42,357$1,813,0000.33%
Zebra Capital Management LLC 6,472$277,0000.32%
Capital Impact Advisors, LLC 19,276$825,0000.27%
Hein Park Capital Management LP 31,977$1,369,0000.26%
CHARTWELL INVESTMENT PARTNERS, LLC 195,340$8,361,0000.25%
Stanley-Laman Group, Ltd. 24,000$1,027,0000.15%
View complete list of EAGLE PHARMACEUTICALS INC shareholders